Semaglutide for the treatment of overweight and obesity: A review
Natasha C. Bergmann(University of Copenhagen), Filip K. Knop(University of Copenhagen)
Cited by 230
Related Papers
Recovery of gut microbiota of healthy adults following antibiotic exposure
|Nature Microbiology|2018|871
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2023|377
Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies
|Annals of the Rheumatic Diseases|2017|146
Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis
|Molecular Metabolism|2020|122